HAE logo

HAE
Haemonetics Corp.

634
Mkt Cap
$2.72B
Volume
550,417.00
52W High
$87.32
52W Low
$47.32
PE Ratio
15.57
HAE Fundamentals
Price
$56.66
Prev Close
$58.46
Open
$58.10
50D MA
$64.04
Beta
0.63
Avg. Volume
1.04M
EPS (Annual)
$3.31
P/B
2.91
Rev/Employee
$450,156.80
$4,182.21
Loading...
Loading...
News
all
press releases
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year
Key PointsInvenomic sold 498,317 shares of Haemonetics Corporation in the fourth quarter...
Nasdaq News: Markets·4d ago
News Placeholder
More News
News Placeholder
Here's Why Haemonetics (HAE) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·7d ago
News Placeholder
London Co. of Virginia Decreases Stake in Haemonetics Corporation $HAE
London Co. of Virginia cut its stake in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 7.1% in the third quarter, according to the company in its most recent disclosure with the SEC...
MarketBeat·8d ago
News Placeholder
Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·9d ago
News Placeholder
Haemonetics Corporation $HAE Shares Purchased by Invenomic Capital Management LP
Invenomic Capital Management LP boosted its stake in Haemonetics Corporation (NYSE:HAE - Free Report) by 1,691.5% in the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·9d ago
News Placeholder
Haemonetics Corporation (NYSE:HAE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Haemonetics Corporation (NYSE:HAE - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven analysts that are currently covering the company...
MarketBeat·9d ago
News Placeholder
Aristotle Capital Boston LLC Increases Stock Position in Haemonetics Corporation $HAE
Aristotle Capital Boston LLC boosted its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 11.4% during the third quarter, according to the company in its most recent filing with the...
MarketBeat·10d ago
News Placeholder
Why Is QuidelOrtho (QDEL) Down 24.5% Since Last Earnings Report?
QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·12d ago
News Placeholder
Haemonetics Corporation $HAE Shares Sold by Schroder Investment Management Group
Schroder Investment Management Group decreased its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 39.7% in the third quarter, according to its most recent Form 13F filing with the...
MarketBeat·12d ago
News Placeholder
Why Is Zimmer (ZBH) Down 2% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·13d ago
<
1
2
...
>

Latest HAE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.